Nurturing eggs with hiPSC-derived cells to improve outcomes in in vitro fertilization.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41650934.
- Also identified by DOI 10.1016/j.stem.2026.01.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical success of in vitro maturation (IVM) for fertility treatment is currently limited by the lack of a reliable source of ovarian support cells (OSCs) to nurture oocytes. Kramme et al. develop "Fertilo," a scalable, clinical-grade hiPSC-derived OSC product that significantly enhances oocyte maturation and improves clinical reproductive outcomes.<sup>1</sup>.
Medical subject headings
- Fertilization in Vitro
- Oocytes
- Induced Pluripotent Stem Cells
- In Vitro Oocyte Maturation Techniques